Juan J. Bustamante

Juan J. Bustamante

Auto-generated profile, based on publicly available information

Juan J. Bustamante

Department of Pharmaceutical Sciences, Rangel College of Pharmacy, Texas A&M Health Sciences Center, Kingsville, TX, USA

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 July 2009 in Liver International
Verified
Journal Article
Closed access
PDF file
BCBryan L. Copple
Bryan L. Copple
JBJuan J. Bustamante
Juan J. Bustamante
TWTimothy P. Welch
Timothy P. Welch
NKNam Deuk Kim
Nam Deuk Kim
JMJeon‐Ok Moon
Jeon‐Ok Moon

16 November 2012 in Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
Verified
Journal Article
Closed access
PDF file
JBJohn D. Bowman
John D. Bowman
HKHyunah Kim
Hyunah Kim
JBJuan J. Bustamante
Juan J. Bustamante

1 November 2011 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
GDGuoli Dai
Guoli Dai
JBJuan J Bustamante
Juan J Bustamante
YZYuhong Zou
Yuhong Zou
AMAndriy Myronovych
Andriy Myronovych
QBQi Bao
Qi Bao
MSMichael J Soares
Michael J Soares
Pregnancy is characterized by physiological adjustments in the maternal compartment. In this investigation, the influence of pregnancy on maternal liver was examined in CD-1 mice. Dramatic changes were observed in the size of the maternal liver during pregnancy. Livers doubled in weight from the non-pregnant state to day 18 of pregnancy. The pregnancy-induced hepatomegaly was a physiological event of liver growth confirmed by DNA content increase and detection of hepatocyte hyperplasia and hypertrophy. Growth of the liver was initiated following implantation and peaked at parturition. The expression and/or activities of key genes known to regulate liver regeneration, a phenomenon of liver growth compensatory to liver mass loss, were investigated. The results showed that pregnancy-dependent liver growth was associated with interleukin (IL)-6, tumor necrosis factor α, c-Jun and IL-1 β, but independent of hepatocyte growth factor, fibroblast growth factor 1, tumor necrosis factor receptor 1, constitutive androstane receptor and pregnane X receptor. Furthermore, maternal liver growth was associated with the activation of hepatic signal transducer and activator of transcription 3, β-catenin and epidermal growth factor receptor, but pregnancy did not activate hepatic c-Met. The findings suggest that the molecular mechanisms regulating pregnancy-induced liver growth and injury-induced liver regeneration exhibit overlapping features but are not identical. In summary, the liver of the mouse adapts to the demands of pregnancy via a dramatic growth response driven by hepatocyte proliferation and size increase.

18 January 2010 in Liver International
Verified
Journal Article
Closed access
PDF file
JBJuan J. Bustamante
Juan J. Bustamante
BCBryan L. Copple
Bryan L. Copple
MSMichael J. Soares
Michael J. Soares
GDGuoli Dai
Guoli Dai

5 November 2018 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HAHamdy E. A. Ali
Hamdy E. A. Ali
PLPei-Yau Lung
Pei-Yau Lung
ASAndrew B. Sholl
Andrew B. Sholl
SGShaimaa A. Gad
Shaimaa A. Gad
JBJuan J. Bustamante
Juan J. Bustamante
Zakaria Y. Abd ElmageedZakaria Y. Abd Elmageed
Zakaria Y. Abd Elmageed
Molecular mechanisms underlying the health disparity of prostate cancer (PCa) have not been fully determined. In this study, we applied bioinformatic approach to identify and validate dysregulated genes associated with tumor aggressiveness in African American (AA) compared to Caucasian American (CA) men with PCa. We retrieved and analyzed microarray data from 619 PCa patients, 412 AA and 207 CA, and we validated these genes in tumor tissues and cell lines by Real-Time PCR, Western blot, immunocytochemistry (ICC) and immunohistochemistry (IHC) analyses. We identified 362 differentially expressed genes in AA men and involved in regulating signaling pathways associated with tumor aggressiveness. In PCa tissues and cells,NKX3.1, APPL2, TPD52, LTC4S, ALDH1A3andAMD1transcripts were significantly upregulated (p < 0.05) compared to normal cells. IHC confirmed the overexpression of TPD52 (p = 0.0098) and LTC4S (p < 0.0005) in AA compared to CA men. ICC and Western blot analyses additionally corroborated this observation in PCa cells. These findings suggest that dysregulation of transcripts in PCa may drive the disparity of PCa outcomes and provide new insights into development of new therapeutic agents against aggressive tumors. More studies are warranted to investigate the clinical significance of these dysregulated genes in promoting the oncogenic pathways in AA men.

1 April 2005 in Protein Science
Verified
Journal Article
Closed access
PDF file
AGAlexei L. Grigorian
Alexei L. Grigorian
JBJuan J. Bustamante
Juan J. Bustamante
PHPeter Hernandez
Peter Hernandez
AMAndrew O. Martinez
Andrew O. Martinez
LHLuis S. Haro
Luis S. Haro